Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,265
Total Claims
$920K
Drug Cost
2,211
Beneficiaries
$416
Cost/Patient
Risk Score Breakdown 32/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
+1086%
Opioid rate vs peers
15.5% vs 1.3% avg
-90%
Cost per patient vs peers
$416 vs $4,034 avg
-76%
Brand preference vs peers
2.2% vs 9.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid prescribing rate is 1,086% above the average for Neurology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
15.5%
Opioid Rate
2,057
Opioid Claims
$36K
Opioid Cost
0.7%
Long-Acting Rate
Brand vs Generic
Brand: 294 claims · $529K
Generic: 12,919 claims · $389K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Pimavanserin Tartrate | 58 | $298K |
| Carbidopa/Levodopa | 1,513 | $66K |
| Rasagiline Mesylate | 93 | $52K |
| Carbidopa/Levodopa | 1,860 | $39K |
| Pregabalin | 40 | $31K |
| Memantine Hcl | 1,596 | $31K |
| Brivaracetam | 33 | $30K |
| Carbidopa/Levodopa | 56 | $25K |
| Oxycodone Hcl/Acetaminophen | 1,051 | $25K |
| Levetiracetam | 693 | $21K |
| Levetiracetam | 320 | $18K |
| Rotigotine | 12 | $9,275 |
| Pregabalin | 282 | $9,224 |
| Pyridostigmine Bromide | 93 | $8,854 |
| Divalproex Sodium | 302 | $8,683 |
Prescribing Profile
46
Unique Drugs
32.0
Anomaly Score
Patient Profile
76
Avg Age
62%
Female
2.61
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About